Belle-Vue-Nursing Home Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-11-2024
- Paid Up Capital ₹ 1.00 M
as on 07-11-2024
- Company Age 41 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.82 Cr
as on 07-11-2024
- Satisfied Charges ₹ 4.66 Cr
as on 07-11-2024
- Revenue 73.42%
(FY 2022)
- Profit 34.32%
(FY 2022)
- Ebitda 11.75%
(FY 2022)
- Net Worth 23.55%
(FY 2022)
- Total Assets 40.21%
(FY 2022)
About Belle-Vue-Nursing Home
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹6.82 Cr. The company has closed loans amounting to ₹4.66 Cr, as per Ministry of Corporate Affairs (MCA) records.
Meena Lulla, Vijay Lulla, and Neelam Rohra serve as directors at the Company.
- CIN/LLPIN
U85110MH1983PTC029800
- Company No.
029800
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 1983
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Belle-Vue-Nursing Home?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Meena Lulla  | Director | 15-Apr-1983 | Current |
| Vijay Lulla | Director | 15-Apr-1983 | Current |
| Neelam Rohra | Whole-Time Director | 02-Jul-2018 | Current |
Financial Performance and Corporate Structure Insights of Belle-Vue-Nursing Home.
Belle-Vue-Nursing Home Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 73.42% increase. The company also saw a substantial improvement in profitability, with a 34.32% increase in profit. The company's net worth Soared by an impressive increase of 23.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Belle-Vue-Nursing Home?
Unlock access to Belle-Vue-Nursing Home's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 28 Apr 2023 | ₹3.07 Cr | Open |
Indian Bank Creation Date: 01 Jun 2022 | ₹3.75 Cr | Open |
Indian Bank Creation Date: 05 Jan 2011 | ₹4.45 Cr | Satisfied |
How Many Employees Work at Belle-Vue-Nursing Home?
Unlock and access historical data on people associated with Belle-Vue-Nursing Home, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Belle-Vue-Nursing Home, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Belle-Vue-Nursing Home's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
